FDA Panel OKs Antibiotic For Pseudomonas in CF

GAITHERSBURG, MD. — Studies of an inhaled formulation of the monobactam antibiotic aztreonam in patients with cystic fibrosis show that it is a safe and effective treatment for Pseudomonas aeruginosa lung infections in this population, most of a federal advisory panel agreed.